Research location
Croydon
United Kingdom
Advertisement
Research activity in Croydon
United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 10 trials and 10 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Croydon
10 linked trials · page 1 of 1Physiological Versus Right Ventricular Outcome Trial Evaluated for Bradycardia Treatment UpgradesNCT06052475 · 2023-09-04 · 1 site observation
RECRUITING
SPCG17: Prostate Cancer Active Surveillance Trigger TrialNCT02914873 · 2016-10-03 · 1 site observation
ACTIVE_NOT_RECRUITING
Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMANNCT02642562 · 2016-08-01 · 1 site observation
COMPLETED
Oral BBR-012 in the Treatment of Diabetic Foot Ulcers, Proof of Concept StudyNCT01342497 · 2011-07-01 · 1 site observation
UNKNOWN
Japanese Single and Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic (PK) & Pharmacodynamic (PD) Study of AZD7687NCT01217905 · 2010-11-01 · 1 site observation
COMPLETED
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart FailureNCT01035255 · 2009-12-01 · 1 site observation
TERMINATED
Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary SyndromeNCT00968708 · 2009-09-01 · 1 site observation
COMPLETED
European Study of Cardiovascular RiskNCT00882336 · 2009-05-01 · 1 site observation
COMPLETED
Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa StudyNCT00255463 · 2004-01-01 · 1 site observation
COMPLETED
Crestor Versus Placebo in Subjects With Heart FailureNCT00206310 · 2003-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.